Anavex Life Sciences Corp (AVXL)

[nidan7500]

georgejji, we need to keep in mind these are non-trivial events w/ schedules for complex, and critically important, scientific studies. Evidence of positive expectation w/bar set at highest level.

IMO, these indicate that AVXL has a strong strategic planning grip (expected results focus ) on the S1R MOA and it's far reaching clinical studies .

[Meeting with FDA for discussing ANAVEX®2-73 Parkinson’s disease program including pivotal Phase 3 study.
Planned initiation of ANAVEX®2-73 imaging-focused Parkinson’s disease clinical study.
Planned initiation of a potentially pivotal Phase 2/3 study in Fragile X Syndrome, the most frequent genetic cause of autism spectrum disorder.
Planned initiation of a Phase 2/3 clinical trial for the treatment of a new rare-disease indication.
Planned initiation of ANAVEX®3-71 Phase 2 clinical trials for FTD, schizophrenias and Alzheimer’s disease indications.Meeting with FDA for discussing ANAVEX®2-73 Parkinson’s disease program including pivotal Phase 3 study.
Planned initiation of ANAVEX®2-73 imaging-focused Parkinson’s disease clinical study.
Planned initiation of a potentially pivotal Phase 2/3 study in Fragile X Syndrome, the most frequent genetic cause of autism spectrum disorder.
Planned initiation of a Phase 2/3 clinical trial for the treatment of a new rare-disease indication.
Planned initiation of ANAVEX®3-71 Phase 2 clinical trials for FTD, schizophrenias and Alzheimer’s disease indications.

https://ih.advfn.com/stock-market/NASDAQ/anavex-life-sciences-AVXL/stock-news/88059881/anavex-life-sciences-provides-business-update-and